| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 52 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 50 |
| 2 | TACROLIMUS OINTMENT 0.1% | 50 |
| 3 | MYCOPHENOLATE MOFETIL | 44 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 44 |
| 5 | PREDNISONE | 39 |
| 6 | PREDNISOLONE | 33 |
| 7 | PREDNISOLONE ORAL | 33 |
| 8 | PREDNISOLONE ORAL SOLUTION | 33 |
| 9 | CYTARABINE | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CASPOFUNGIN ACETATE | 8 | 0.0050 |
| 1 | GRISEOFULVIN | 1 | 0.0034 |
| 2 | MITOXANTRONE HYDROCHLORIDE | 11 | 0.0017 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 14 | 0.0017 |
| 4 | FLUCYTOSINE | 2 | 0.0014 |
| 5 | CIDOFOVIR ANHYDROUS | 2 | 0.0014 |
| 6 | AMPHOTERICIN B LIPOSOME | 3 | 0.0013 |
| 7 | CALASPARGASE PEGOL | 1 | 0.0012 |
| 8 | AMPHOTERICIN B | 14 | 0.0011 |
| 9 | IMIPENEM AND CILASTATIN SODIUM | 2 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 85 |
| 1 | Azole Antifungal [EPC] | 37 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 26 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 22 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 16 |
| 5 | Polyene Antifungal [EPC] | 16 |
| 6 | Alkylating Drug [EPC] | 15 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 14 |
| 8 | Glycopeptide Antibacterial [EPC] | 14 |
| 9 | Asparagine-specific Enzyme [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |
| 1 | Nucleoside Analog Antifungal [EPC] | 2 | 0.0014 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 16 | 0.0012 |
| 3 | Asparagine-specific Enzyme [EPC] | 12 | 0.0009 |
| 4 | Allylamine Antifungal [EPC] | 6 | 0.0008 |
| 5 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 6 | Echinocandin Antifungal [EPC] | 5 | 0.0006 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 9 | 0.0004 |
| 8 | Polyene Antifungal [EPC] | 16 | 0.0004 |
| 9 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |